Wednesday, September 17, 2014 4:02:38 PM
The bio presented was from 2005. To discover the fate of DOV/DOVP shareholders
please see Post 39132. That being said, aside from collecting government paychecks,
he has participated in a successful IPO, which gives him one up on Varney. Perhaps some
of the sources of funding for that IPO had the chance to cash out before the stock crashed.
If so maybe they can be depended upon for funding these trials. I would, however, feel
better if I knew the trials were funded in part by HELOCs on management's, and the B.O.D.'s private
residences. So much for wishful thinking.
In regards to Lippa's mention of Joan Rivers, and the King of Pop's demise, both illustrate how
over-medicated and over-procedured our society has become. As long as patients insist on
pain control measures that far outstrip medical necessity, and as long as patients submit to elective
procedures well into their 80's and 90's, and as long as there are medical professionals who
accommodate those whims, ampakines for R.D. rescue have a bright future.
It might as well be Lippa, and CORX who cater to, and profit from our cultural overmedication.
I am long this stock despite my misgivings, and I think many others will be as well in the not too
distant future.
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM